Effects of in vitro and in vivo opioids on the production of IL-12 and IL-10 by murine macrophages

Annals of the New York Academy of Sciences

Volumn 992, Issue , 2003, Pages 129-140

  Sacerdote, Paola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cytokines; Interleukin 10; Interleukin 12; Macrophages; Morphine; Opioids; Tolerance

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; INTERLEUKIN 10; INTERLEUKIN 12; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALTREXONE; OPIATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PERITONEUM MACROPHAGE;

ANIMALIA; MURINAE;

EID: 0037791749     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03144.x     Document Type: Conference Paper

References (24)

1. LYSLE, D.T., M.E. COUSSONS, V.J. WATTS, et al. 1993. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265: 1071-1078.
2. PANERAI, A.E. & P. SACERDOTE. 1997. Beta-endorphin in the immune system: a role at last. Immunol. Today 18: 317-319.
3. SACERDOTE, P., B. MANFREDI P. MANTEGAZZA & A.E. PANERAI. 1997. Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. Br. J. Pharmacol. 121: 834-840.
4. EISENSTEIN, T.K. & M.E. HILLBURGER. 1998. Opioid modulation of immune responses: effects on phagocyte and lymphoyd cell populations. J. Neuroimmunol. 83: 36-44.
5. MILLER, J.A., S.J. HOPKINS & G.N. LUHESHI. 1997. Sites of action of IL-1 in the development of fever and cytokine responses to tissue inflammation in the rat. Br. J. Pharmacol. 120: 1274-1279.
6. BEUTLER, B. & A. CERAMI. 1989. The biology of cachectin/TNF-a primary mediator of the host response. Annu. Rev. Immunol. 7: 625-655.
7. TRINCHERI, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen specific adaptive immunity. Annu. Rev. Immunol. 13: 251-276.
8. MOSMAN, T.R. & S. SAD. 1996. The expanding universe of T-cell subsets; Thl,Th2 and more. Immunol. Today 17: 138-146.
9. LIMIROLI, E., L. GASPANI, A.E. PANERAI & P. SACERDOTE. 2002. Differential tolerance development in the modulation of macrophage cytokine production in mice. J. Leukocyte Biol. 72: 43-48.
10. SACERDOTE, P., B. MANFREDI, L. GASPANI & A.E. PANERAI. 2000. The opioid antagonist naloxone induces a shift from type I cytokine pattern to type 2 cytokine pattern in balb/cJ mice. Blood 95: 2031-2036.
11. WEST, J.P., L.A. DYKSTRA & D.T. LYSLE. 1997. Tolerance development to morphine-induced alterations of immune status administration. Drug Alcohol Depend. 46: 147-157.
12. WEST, J.P., L.A. DYKSTRA & D.T. LYSLE. 1998. Differential tolerance to morphine's immunomodulatory effects following continuous administration. Drug Alcohol Depend. 53: 31-38.
13. BAYER, B.M., M.C. HERNANDEZ & X.Z. DING. 1994. Tolerance and crosstolerance to the suppressive effects of cocaine and morphine on lymphocyte proliferation. Pharmacol. Biochem. Behav. 53: 227-234.
14. BAYER, B.M., R.M. BRECHIO, X.Z. DING & M.C. HERNANDEZ. 1994. Enhanced susceptibility of the immune system to stress in morphine-tolerant rats. Brain Behav. Immun. 8: 173-184.
15. MASSI, P., A. VACCANI, S. ROMORINI & D. PAROLARO. 2001. Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects. J. Neuroimmunol. 117: 116-124.
16. BRYANT, H.U., E.W. BERNTON & J.W. HOLADAY. 1988. Morphine pellet-induced immunomodulation in mice: temporal relationships. J. Pharmacol. Exp. Ther. 246: 913-920.
17. BUSSIERE, L.J., M.W. ADLER, T.J. ROGERS & T.K. EISENSTEIN. 1993. Cytokine reversal of morphine-induced suppression of the antibody response. J. Pharmacol. Exp. Ther. 264: 591-597.
18. BHARGAVA, H.N., P.T. THOMAS, S. THORAT & R.V. HOUSE. 1994. Effect of morphine tolerance and abstinence on cellular immune responses. Brain Res. 642: 1-10.
19. MCCARTHY, L., M. WETZEL, J.K. SLIKER & T.K. EISENSTEIN, et al. 2001. Opioids, opioid receptors and the immune response. Drug Alcohol Depend. 62: 111-123.
20. MADDEN, J.J., W.L. WHALEY, D. KETELSEN & R.M. DONAHOE. 2001. The morphine-binding site on human activated T-cells is not related to the mu opioid receptor. Drug Alcohol Depend. 62: 131-139.
21. SACERDOTE P., P. MANTEGAZZA & A.E. PANERAI. 1985. Analgesic effects of mu antagonists after naloxone non-reversible stress induced analgesia. Brain Res. 359: 34-38.
22. BIANCHI, M., P. SACERDOTE, L. LOCATELLI, P. MANTEGAZZA, et al. 1991. Corticotropin releasing hormone, interleukin 1-alpha, and tumor necrosis factor alpha share characteristics of stress mediators. Brain Res. 546: 139-142.
23. BIANCHI, M. & A.E. PANERAI. 1993. Naloxone-induced analgesia; involvement of k-opiate receptors. Pharmacol. Biochem. Behav. 46: 145-148.
24. FERREIRA, S.H. 1980. Peripheral analgesia: mechanism of the analgesic action of aspirin-like drugs and opiate antagonists. Br. J. Clin. Pharmacol. 2: 237-245.